HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Milos P Stojiljković Selected Research

heptenophos

12/2011[Antidotal effect of combinations obidoxime/HI-6 and memantine in mice poisoned with soman, dichlorvos or heptenophos].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Milos P Stojiljković Research Topics

Disease

3Organophosphate Poisoning
12/2011 - 12/2006
2Poisoning
12/2011 - 12/2006
2Inflammation (Inflammations)
03/2009 - 01/2009
1Fasciculation (Fasciculations)
12/2011
1Myocardial Ischemia (Ischemic Heart Diseases)
05/2002
1Premature Obstetric Labor (Premature Labor)
05/2002

Drug/Important Bio-Agent (IBA)

3OximesIBA
12/2011 - 12/2006
2Obidoxime Chloride (Obidoxime)IBA
12/2011 - 12/2006
2SomanIBA
12/2011 - 12/2006
2asoxime chloride (H16)IBA
12/2011 - 12/2006
2Simvastatin (Zocor)FDA LinkGeneric
03/2009 - 01/2009
1Memantine (Namenda)FDA Link
12/2011
1heptenophosIBA
12/2011
1DichlorvosIBA
12/2011
1AtropineFDA LinkGeneric
12/2011
1Indomethacin (Indometacin)FDA LinkGeneric
03/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2009
1CarrageenanIBA
03/2009
1CytokinesIBA
01/2009
1EndotoxinsIBA
01/2009
1LipopolysaccharidesIBA
01/2009
1tabunIBA
12/2006
1VX (EDIM)IBA
12/2006
1pralidoxime (Protopam Chloride)FDA Link
12/2006
1cyclohexyl methylphosphonofluoridate (cyclosarin)IBA
12/2006
1Nerve AgentsIBA
12/2006
1Cholinesterase ReactivatorsIBA
12/2006
1Cholinesterases (Cholinesterase)IBA
12/2006
1InsecticidesIBA
12/2006
1Organophosphorus CompoundsIBA
12/2006
1SarinIBA
12/2006
1Trimedoxime (Trimedoxime Bromide)IBA
12/2006
1Ritodrine (Yutopar)FDA Link
05/2002

Therapy/Procedure

2Therapeutics
12/2011 - 05/2002